نتایج جستجو برای: activating mutation

تعداد نتایج: 342144  

Journal: :Blood 2014
Lorraine Springuel Tekla Hornakova Elisabeth Losdyck Fanny Lambert Emilie Leroy Stefan N Constantinescu Elisabetta Flex Marco Tartaglia Laurent Knoops Jean-Christophe Renauld

The acquisition of growth signal self-sufficiency is 1 of the hallmarks of cancer. We previously reported that the murine interleukin-9-dependent TS1 cell line gives rise to growth factor-independent clones with constitutive activation of the Janus kinase (JAK)- signal transducer and activator of transcription (STAT) pathway. Here, we show that this transforming event results from activating mu...

Severe Combined Immunodeficiency (SCID), characterized by a profound decrease in both the number and function of T cells, is related to more than 20 different mutations. Recombination-activating gene (RAG) 1 and 2 seem to be two of the most common forms presenting with various manifestations, including typical SCID, Omenn syndrome (OS), atypical SCID (AS), or delayed onset combined immunodefici...

Journal: :Blood 2003
Soheil Meshinchi Derek L Stirewalt Todd A Alonzo Quangeng Zhang David A Sweetser William G Woods Irwin D Bernstein Robert J Arceci Jerald P Radich

Activating mutations of receptor tyrosine kinases (RTKs) and their downstream affectors are common in acute myeloid leukemia (AML). We performed mutational analysis of FLT3, c-kit, c-fms, vascular endothelial growth factor (VEGF) receptors (Flt-1, KDR [kinase domain receptor]), and ras genes in a group of 91 pediatric patients with AML treated on Children's Cancer Group clinical trial CCG-2891....

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Kazuya Taniguchi Junji Uchida Kazumi Nishino Toru Kumagai Takako Okuyama Jiro Okami Masahiko Higashiyama Ken Kodama Fumio Imamura Kikuya Kato

PURPOSE Examination of somatic epidermal growth factor receptor (EGFR) mutations is now a diagnostic routine for treatment of cancer using EGFR tyrosine kinase inhibitors (EGFR-TKI). Circulating tumor DNA is a promising target for noninvasive diagnostics. We evaluated its utility by quantitatively detecting activating and resistant mutations, which were measured with BEAMing (beads, emulsion, a...

Journal: :Human pathology 2014
Ryosuke Nomura Tsuyoshi Saito Hiroyuki Mitomi Yasuhiro Hidaka Se-yong Lee Sumio Watanabe Takashi Yao

Gastric adenocarcinoma of the fundic gland type (GAFG) is a rare variant of gastric tumor. We have recently reported the frequent accumulation of β-catenin in GAFGs and showed that approximately half of the cases studied harbored at least 1 mutation in CTNNB1/AXINs/APC, leading to the constitutive activation of the Wnt/β-catenin pathway. However, the mechanisms of Wnt signaling activation in th...

Journal: :European journal of endocrinology 2000
S Kosugi N Hai H Okamoto H Sugawa T Mori

OBJECTIVE A number of activating mutations of the thyrotropin receptor (TSHR) have been found in autonomously functioning thyroid nodules (AFTNs) in European patients. We aimed to study TSHR mutation in AFTNs in Japanese patients because no TSHR activating mutation has been found by previous incomplete studies. DESIGN A typical AFTN developed in a 69-year-old Japanese woman was studied. MET...

2012
Pierre-Jean Lamy William Jacot

Two studies recently reported around 10% of EGFR activating mutations in triple negative breast cancers from Asian patients. However, we did not find any EGFR activating mutation in a series of 229 breast tumor samples from European patients. Like in lung cancer, the EGFR mutation profiles seem to be related to the ethnical origin of patients. This is an important point that should be considere...

Journal: :Frontiers in bioscience : a journal and virtual library 2000
S M Wu E W Leschek O M Rennert W Y Chan

Human male sexual development is regulated by chorionic gonadotropin (CG) and luteinizing hormone (LH). Aberrant sexual development caused by both activating and inactivating mutations of the human luteinizing hormone receptor (LHR) have been described. All known activating mutations of the LHR are missense mutations caused by single base substitution. The most common activating mutation is the...

Bita Geramizadeh, Zahra Jowkar Zeinab Ranjbar

Background: Gastrointestinal stromal tumor (GIST) is the most common mesenchymal neoplasm of the gastrointestinal tract. They are believed to originate from the interstitial cells of Cajal. Most of these tumors contain activating mutations in the KIT receptor tyrosine kinase. This is the first study in Iran to evaluate GISTs at the molecular level.Methods: In the present study, during 5 years (...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید